Search details
1.
The long non-coding RNA NRON promotes the development of cardiac hypertrophy in the murine heart.
Mol Ther
; 30(3): 1265-1274, 2022 03 02.
Article
in English
| MEDLINE | ID: mdl-34856383
2.
Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction.
Circulation
; 141(9): 751-767, 2020 03 03.
Article
in English
| MEDLINE | ID: mdl-31948273
3.
Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy.
Eur Heart J
; 41(36): 3462-3474, 2020 09 21.
Article
in English
| MEDLINE | ID: mdl-32657324
4.
Pleiotropic cardiac functions controlled by ischemia-induced lncRNA H19.
J Mol Cell Cardiol
; 146: 43-59, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32649928
5.
Quaking Inhibits Doxorubicin-Mediated Cardiotoxicity Through Regulation of Cardiac Circular RNA Expression.
Circ Res
; 122(2): 246-254, 2018 01 19.
Article
in English
| MEDLINE | ID: mdl-29133306
6.
Inhibition of the Cardiac Fibroblast-Enriched lncRNA Meg3 Prevents Cardiac Fibrosis and Diastolic Dysfunction.
Circ Res
; 121(5): 575-583, 2017 Aug 18.
Article
in English
| MEDLINE | ID: mdl-28630135
7.
MicroRNA-Based Therapy of GATA2-Deficient Vascular Disease.
Circulation
; 134(24): 1973-1990, 2016 Dec 13.
Article
in English
| MEDLINE | ID: mdl-27780851
8.
Noncoding RNAs in Heart Failure.
Handb Exp Pharmacol
; 243: 423-445, 2017.
Article
in English
| MEDLINE | ID: mdl-27995387
9.
Osteopontin is indispensible for AP1-mediated angiotensin II-related miR-21 transcription during cardiac fibrosis.
Eur Heart J
; 36(32): 2184-96, 2015 Aug 21.
Article
in English
| MEDLINE | ID: mdl-25898844
10.
In vitro Assays and Imaging Methods for Drug Discovery for Cardiac Fibrosis.
Front Physiol
; 12: 697270, 2021.
Article
in English
| MEDLINE | ID: mdl-34305651
11.
Cardiac Fibroblast Growth Factor 23 Excess Does Not Induce Left Ventricular Hypertrophy in Healthy Mice.
Front Cell Dev Biol
; 9: 745892, 2021.
Article
in English
| MEDLINE | ID: mdl-34778257
12.
Pharmacokinetic Studies of Antisense Oligonucleotides Using MALDI-TOF Mass Spectrometry.
Front Pharmacol
; 11: 220, 2020.
Article
in English
| MEDLINE | ID: mdl-32269522
13.
MiRNA-181a is a novel regulator of aldosterone-mineralocorticoid receptor-mediated cardiac remodelling.
Eur J Heart Fail
; 22(8): 1366-1377, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32304626
14.
Preclinical development of a miR-132 inhibitor for heart failure treatment.
Nat Commun
; 11(1): 633, 2020 01 31.
Article
in English
| MEDLINE | ID: mdl-32005803
15.
Long Noncoding RNA-Enriched Vesicles Secreted by Hypoxic Cardiomyocytes Drive Cardiac Fibrosis.
Mol Ther Nucleic Acids
; 18: 363-374, 2019 Dec 06.
Article
in English
| MEDLINE | ID: mdl-31634682
16.
Preclinical Development of a MicroRNA-Based Therapy for Elderly Patients With Myocardial Infarction.
J Am Coll Cardiol
; 68(14): 1557-71, 2016 10 04.
Article
in English
| MEDLINE | ID: mdl-27687198
17.
Long noncoding RNA Chast promotes cardiac remodeling.
Sci Transl Med
; 8(326): 326ra22, 2016 Feb 17.
Article
in English
| MEDLINE | ID: mdl-26888430
18.
Regulatory RNAs and paracrine networks in the heart.
Cardiovasc Res
; 102(2): 290-301, 2014 May 01.
Article
in English
| MEDLINE | ID: mdl-24562768
19.
Cardiac myocyte-secreted cAMP exerts paracrine action via adenosine receptor activation.
J Clin Invest
; 124(12): 5385-97, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25401477
20.
Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy.
J Clin Invest
; 124(5): 2136-46, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24743145